"US Digital Pathology Market is valued at USD 786.19 Million in 2018 and expected to reach USD 1,678.63 Million by 2025 with the CAGE of 11.45% over the forecast period."
The latest report pertaining to US Digital Pathology Market provides a detailed analysis regarding market size, revenue estimations and growth rate of the industry. In addition, the report illustrates the major obstacles and newest growth strategies adopted by leading manufacturers who are a part of the competitive landscape of this market.
Key Players US Digital Pathology Market Reports-
US Digital Pathology Market report covers prominent players are F. Hoffmann-La Roche Ltd , Ventana Medical Systems, Hamamatsu Photonics,3DHISTECH, Koninklijke Philips, Huron Digital Pathology, Visiopharm, Corista, Indica Labs, XIFIN & Leica Biosystem and Others.
US Digital Pathology Market Dynamics –
Increasing prevalence of chronic diseases, growing adoption of digital pathology products for improving the efficiency of laboratories around the world. According to the World Health Organization (WHO), the second-leading cause of death around the world is cancer, which was responsible for 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer and approximately 70% of deaths from cancer occur in low- and middle-income countries. Moreover, the geriatric population is more liable to different chronic diseases like cardiovascular diseases; the requirement for teleconsultations will increase growth of market. As per WHO , about 17.9 million people die every year due to cardiovascular diseases (CVDs), an estimated 31% of the global deaths However, High investment research and developments and expensive procedure during disease diagnosis will hamper the growth of US Digital Pathology Market. Moreover, Due to technological advancements in healthcare sectors and increasing government initiatives and collaboration with market players for raising awareness regarding the innovative digital pathology technologies and products is predicted to create wide opportunities for the players operating in the US Digital Pathology Market during forecast period.
US Digital Pathology Market Regional Analysis –
North America is dominating the US Digital Pathology Market with the potential rate due to rising awareness among the people about advanced diagnosis in healthcare. Increasing number of cases of cancer in the United States will helps in growth of the US Digital Pathology Market. As per National Institutes of Health, an estimated 1,735,350 new cases of cancer will be diagnosed in the United States in 2018. Moreover, increasing number of players are entering the US Digital Pathology Market with varied service offerings in the region.
Key Benefits for US Digital Pathology Market Reports –
US Digital Pathology Market Segmentation –
By End User:
Get Sample Copy of This Premium Report @https://brandessenceresearch.com/requestSample/PostId/454
Interested in this report?